What LeonaBio Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 10 |
| Total trades | 1 | 25 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 776,648 | 2,166,899 |
| Disposed | 0 | 16,748 |
| Net activity | +776,648 | +2,150,151 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors Llc | Director | Oct 26 | Exercise / conversion · M | +776,648 | $0.00 | +$777 | 776,648 |
| Litton Mark James | PRESIDENT and CEO | Mar 04 | Open-market sale · S | −5,156 | $5.37 | −$27.7K | 57,926 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Mar 04 | Open-market sale · S | −1,720 | $5.37 | −$9.24K | 15,887 |
| Church Kevin | CHIEF SCIENTIFIC OFFICER | Mar 04 | Open-market sale · S | −1,359 | $5.37 | −$7.3K | 25,178 |
| Worthington Mark | GENERAL COUNSEL and CCO | Mar 04 | Open-market sale · S | −1,328 | $5.37 | −$7.13K | 18,376 |
| Renninger Robert | CHIEF FINANCIAL OFFICER | Mar 04 | Open-market sale · S | −906 | $5.37 | −$4.87K | 15,851 |
| Litton Mark James | PRESIDENT and CEO | Mar 03 | Exercise / conversion · M | +22,254 | — | — | 63,082 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Mar 03 | Exercise / conversion · M | +7,418 | — | — | 17,607 |
| Church Kevin | CHIEF SCIENTIFIC OFFICER | Mar 03 | Exercise / conversion · M | +5,856 | — | — | 26,537 |
| Worthington Mark | GENERAL COUNSEL and CCO | Mar 03 | Exercise / conversion · M | +5,726 | — | — | 19,704 |
| Renninger Robert | CHIEF FINANCIAL OFFICER | Mar 03 | Exercise / conversion · M | +3,900 | — | — | 16,757 |
| Litton Mark James | President and CEO | Jan 02 | Open-market sale · S | −2,586 | $6.88 | −$17.8K | 40,828 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Jan 02 | Open-market sale · S | −1,644 | $6.88 | −$11.3K | 10,189 |
| Church Kevin | CHIEF SCIENTIFIC OFFICER | Jan 02 | Open-market sale · S | −876 | $6.88 | −$6.03K | 20,681 |
| Worthington Mark | General Counsel and CCO | Jan 02 | Open-market sale · S | −876 | $6.88 | −$6.03K | 13,978 |
| Renninger Robert | Chief Financial Officer | Jan 02 | Open-market sale · S | −297 | $6.88 | −$2.04K | 12,857 |
| Litton Mark James | President and CEO | Dec 31 | Exercise / conversion · M | +10,834 | — | — | 43,414 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Dec 31 | Exercise / conversion · M | +4,667 | — | — | 11,833 |
| Church Kevin | CHIEF SCIENTIFIC OFFICER | Dec 31 | Exercise / conversion · M | +3,667 | — | — | 21,557 |
| Worthington Mark | General Counsel and CCO | Dec 31 | Exercise / conversion · M | +3,667 | — | — | 14,854 |
Loading...
